{
    "symbol": "BXP",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-03 15:13:09",
    "content": " So in summary, we had another active and successful quarter with strong leasing and financial returns and continue to forecast significant growth in our FFO per share this year, driven by strong leasing activity, continued recovery of variable revenue streams, delivery of a well-leased development pipeline completion of new acquisitions, both last year and this year, a rapidly expanding life science portfolio in the nation's hottest life science markets and well-timed refinancing activity in 2021 and lower capital costs."
}